Open access
Aug 2026
SNX4 promotes glioblastoma progression through the TGFβ1/Smad signaling pathway and represents a potential therapeutic target
The findings suggest that SNX4 functions as an important regulator of GBM progression, may serve as a potential prognostic biomarker for glioma patients, and may represent a potential therapeutic target.
Zhipeng Yao, Pengcheng Xu, T. Shen et al.
· Journal of Translational Med... · 0 citations